Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 Apr 3.

Published in final edited form as: Lancet. 2021 Apr 3;397(10281):1276–1292. doi: 10.1016/S0140-6736(21)00314-7

Figure 2. — Viral suppression across study weeks before delivery

(A) Proportion of participants with viral suppression (defined as a HIV-1 concentration of <200 copies per mL) from study entry to delivery. Error bars show 95% CIs. (B) Estimated probability of not achieving viral suppression between randomisation and delivery. The grey dashed line indicates overall mean duration of follow-up from randomisation to delivery.

Figure 2. — Viral suppression across study weeks before delivery

(A) Proportion of participants with viral suppression (defined as a HIV-1 concentration of <200 copies per mL) from study entry to delivery. Error bars show 95% CIs. (B) Estimated probability of not achieving viral suppression between randomisation and delivery. The grey dashed line indicates overall mean duration of follow-up from randomisation to delivery.